Gerald Lee, MD; Stanley Fineman, MD; Iris Otani, MD; Disclosures
Recorded 1/24/2025
AllergyWatch issue Nov/Dec 2024
To download the mp3 file, right click on the player and select Save audio as.
Interested in claiming CME for this episode? Click here
Show Notes
Welcome to another episode of Allergy Talk, a roundup of the latest in the field of Allergy and Immunology by the American College of Allergy, Asthma, and Immunology. For today’s episode we will be reviewing articles from Allergy Watch, a bimonthly publication which provides research summaries to College members from the major journals in allergy and immunology.
Today we are joined by Dr. Iris Otani, an associate professor of medicine at UCSF and an assistant editor of Allergy Watch. We will be reviewing the November-December 2024 issue Allergy Watch, a bimonthly publication which provides research summaries to College members from the major journals in allergy and immunology.
To read archived issues of Allergy Watch, head over to https://college.acaai.org/publications/allergywatch. Also, make sure you check out the ACAAI Community on DocMatter where we can continue the discussion about these articles!
Articles Reviewed:
- Effect of Azithromycin on Asthma Remission in Adults With Persistent Uncontrolled Asthma: A Secondary Analysis of a Randomized, Double-Anonymized, Placebo-Controlled Trial
- Polyethylene glycol hypersensitivity, patient outcomes in a 7-year retrospective study.
- Patients taking benralizumab, dupilumab, or mepolizumab have lower postvaccination SARS-CoV-2 immunity.
ACAAI is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced.
Speaker Disclosures back to top
Gerald Lee, MD
No relevant financial relationships with ineligible companies to disclose
Stanley Fineman, MD
Researcher: Novartis, Aimmune, DBV
Speaker: Genentech
Iris Otani, MD
Consultant: CSL Behring, Change Healthcare, Adivo Associates